210 related articles for article (PubMed ID: 29470731)
1. Sacral neuromodulation versus personalized conservative treatment in patients with idiopathic slow-transit constipation: study protocol of the No.2-trial, a multicenter open-label randomized controlled trial and cost-effectiveness analysis.
Heemskerk SCM; Rotteveel AH; Benninga MA; Baeten CIM; Masclee AAM; Melenhorst J; van Kuijk SMJ; Dirksen CD; Breukink SO
Int J Colorectal Dis; 2018 Apr; 33(4):493-501. PubMed ID: 29470731
[TBL] [Abstract][Full Text] [Related]
2. Sacral Neuromodulation Versus Conservative Treatment for Refractory Idiopathic Slow-transit Constipation: The Randomized Clinical No.2-Trial.
Heemskerk SCM; Dirksen CD; van Kuijk SMJ; Benninga MA; Baeten CIM; Masclee AAM; Melenhorst J; Breukink SO
Ann Surg; 2024 May; 279(5):746-754. PubMed ID: 37991178
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of sacral neuromodulation for chronic refractory constipation in children and adolescents: a Markov model analysis.
van der Wilt AA; Groenewoud HHM; Benninga MA; Dirksen CD; Baeten CGMI; Bouvy ND; Melenhorst J; Breukink SO
Colorectal Dis; 2017 Nov; 19(11):1013-1023. PubMed ID: 28834055
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness, safety and cost-effectiveness of sacral neuromodulation for idiopathic slow-transit constipation: a systematic review.
Heemskerk SCM; van der Wilt AA; Penninx BMF; Kleijnen J; Melenhorst J; Dirksen CD; Breukink SO
Colorectal Dis; 2024 Mar; 26(3):417-427. PubMed ID: 38247282
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome of intractable constipation treated by sacral neuromodulation: a comparison between children and adults.
Janssen PTJ; Meyer YM; Van Kuijk SMJ; Benninga MA; Stassen LPS; Bouvy ND; Melenhorst J; Breukink SO
Colorectal Dis; 2018 Feb; 20(2):134-143. PubMed ID: 28782277
[TBL] [Abstract][Full Text] [Related]
6. Sacral nerve stimulation for intractable constipation.
Kamm MA; Dudding TC; Melenhorst J; Jarrett M; Wang Z; Buntzen S; Johansson C; Laurberg S; Rosen H; Vaizey CJ; Matzel K; Baeten C
Gut; 2010 Mar; 59(3):333-40. PubMed ID: 20207638
[TBL] [Abstract][Full Text] [Related]
7. Sacral neuromodulation therapy: a promising treatment for adolescents with refractory functional constipation.
van Wunnik BP; Peeters B; Govaert B; Nieman FH; Benninga MA; Baeten CG
Dis Colon Rectum; 2012 Mar; 55(3):278-85. PubMed ID: 22469794
[TBL] [Abstract][Full Text] [Related]
8. Sacral neuromodulation in children and adolescents with chronic constipation refractory to conservative treatment.
van der Wilt AA; van Wunnik BP; Sturkenboom R; Han-Geurts IJ; Melenhorst J; Benninga MA; Baeten CG; Breukink SO
Int J Colorectal Dis; 2016 Aug; 31(8):1459-66. PubMed ID: 27294660
[TBL] [Abstract][Full Text] [Related]
9. Sacral nerve stimulation in slow-transit constipation: effectiveness at 5-year follow-up.
Schiano di Visconte M; Pasquali A; Cipolat Mis T; Brusciano L; Docimo L; Bellio G
Int J Colorectal Dis; 2019 Sep; 34(9):1529-1540. PubMed ID: 31309325
[TBL] [Abstract][Full Text] [Related]
10. Sacral neuromodulation for constipation and fecal incontinence in children and adolescents - study protocol of a prospective, randomized trial on the application of invasive vs. non-invasive technique.
Besendörfer M; Kirchgatter A; Carbon R; Weiss C; Müller H; Matzel KE; Diez S
Trials; 2024 Mar; 25(1):210. PubMed ID: 38515199
[TBL] [Abstract][Full Text] [Related]
11. Short-term effects of magnetic sacral dermatome stimulation for idiopathic slow transit constipation: sham-controlled, cross-over pilot study.
Lee KJ; Kim JH; Cho SW
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):47-53. PubMed ID: 16706811
[TBL] [Abstract][Full Text] [Related]
12. CON-COUR study: Interferential therapy in the treatment of chronic constipation in adults: study protocol for a randomized controlled trial.
Vitton V; Benezech A; Honoré S; Sudour P; Lesavre N; Auquier P; Baumstarck K
Trials; 2015 May; 16():234. PubMed ID: 26012788
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of sacral neuromodulation compared to botulinum neurotoxin a or continued medical management in refractory overactive bladder.
Arlandis S; Castro D; Errando C; Fernández E; Jiménez M; González P; Crespo C; Staeuble F; Rodríguez JM; Brosa M
Value Health; 2011; 14(2):219-28. PubMed ID: 21402292
[TBL] [Abstract][Full Text] [Related]
14. Treatment of slow-transit constipation with sacral nerve modulation.
Naldini G; Martellucci J; Moraldi L; Balestri R; Rossi M
Colorectal Dis; 2010 Nov; 12(11):1149-52. PubMed ID: 19843118
[TBL] [Abstract][Full Text] [Related]
15. Sacral Nerve Stimulation Fails to Offer Long-term Benefit in Patients With Slow-Transit Constipation.
Patton V; Stewart P; Lubowski DZ; Cook IJ; Dinning PG
Dis Colon Rectum; 2016 Sep; 59(9):878-85. PubMed ID: 27505117
[TBL] [Abstract][Full Text] [Related]
16. Neuromodulation for constipation: sacral and transcutaneous stimulation.
van Wunnik BP; Baeten CG; Southwell BR
Best Pract Res Clin Gastroenterol; 2011 Feb; 25(1):181-91. PubMed ID: 21382589
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcome of sacral neuromodulation for chronic refractory constipation.
Maeda Y; Kamm MA; Vaizey CJ; Matzel KE; Johansson C; Rosen H; Baeten CG; Laurberg S
Tech Coloproctol; 2017 Apr; 21(4):277-286. PubMed ID: 28429130
[TBL] [Abstract][Full Text] [Related]
18. Treatment efficacy of sacral nerve stimulation in slow transit constipation: a two-phase, double-blind randomized controlled crossover study.
Dinning PG; Hunt L; Patton V; Zhang T; Szczesniak M; Gebski V; Jones M; Stewart P; Lubowski DZ; Cook IJ
Am J Gastroenterol; 2015 May; 110(5):733-40. PubMed ID: 25895520
[TBL] [Abstract][Full Text] [Related]
19. [Sacral neuromodulation in the treatment of intractable constipation].
Zheng J; Li S; Nie Y; Sun H; Wang M; Dai Y; Zhao H; Pang G; Wu G; Zhao Q
Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Dec; 17(12):1175-8. PubMed ID: 25529946
[TBL] [Abstract][Full Text] [Related]
20. Noninvasive Sacral Neuromodulation in Children and Adolescents: A Case-Control Study of Patients With Chronic Refractory Constipation.
Diez S; Kirchgatter A; Adam D; Füldner A; Müller H; Matzel KE; Besendörfer M
Neuromodulation; 2023 Dec; 26(8):1858-1866. PubMed ID: 36207226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
